医学
粘膜切除术
随机对照试验
结肠镜检查
不利影响
外科
子群分析
内科学
胃肠病学
内窥镜检查
置信区间
结直肠癌
癌症
作者
Óscar Nogales,Carlos Carbonell-Blanco,Sheyla Montori,María Pellisé,Juan Martínez-Sempere,Faust Riu,Carolina Mangas‐Sanjuán,María Daca-Álvarez,Hugo Uchima,Javier Aranda Hernández,Alberto Álvarez Delgado,Enrique Rodríguez de Santiago,José Santiago García,Ángel Cañete Ruiz,Pablo Miranda García,Henar Núñez,Alberto Herreros de Tejada,Eduardo Valdivielso Cortázar,P de María,David Busquets
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2025-02-19
摘要
Backgrounds and Aims: Cold snare EMR (CS-EMR) in large flat non-pedunculated colonic lesions (LFNPCLs) is an alternative to the standard EMR procedure with a better safety profile, but scientific evidence on its efficacy is unavailable. Primary objective: To compare the recurrence rate between the two techniques at six months. Secondary objectives: comparison of the safety profile and several procedure-related outcomes. Patients and methods: This was a noninferiority, multicentric, open-label, randomized controlled trial of consecutive large (>20 mm) LFNPCLs without suspicious features of submucosal invasion. Results: A total of 229 patients were randomized to receive CS-EMR (n=115) or EMR (n=114), with adenomas (76.4%) and a median size of 25 mm. The trial was stopped early by clinical consensus according to a safety monitoring board. At first surveillance colonoscopy (n=220) the recurrence rate (RR) was significantly greater in the CS-EMR group than in the EMR group: 33.0% vs. 16.2% (p=0.004) and 34.7% vs. 14.8% (p=0.001) in the ITT and PP analyses, respectively. According to the subgroup analysis, the RR was significantly greater for LFNPCLs >30 mm (18.2% EMR vs. 43.1% CS-EMR). There was no difference in the rate of adverse events. The use of clips was more common in the EMR group (2.21 vs. 1.30). Conclusions: Compared with the conventional hot technique, the RR of LFNPCL after CS-EMR was significantly greater. A similar safety profile was found between groups.
科研通智能强力驱动
Strongly Powered by AbleSci AI